Viewpoint

The European Commission’s work to secure access to potential COVID-19 vaccines is welcome, but other therapies are needed to end the pandemic and negotiations with European manufacturers of anti-viral antibodies should not be further delayed

Viewpoint: The success of open science depends on protecting academic data from commercial exploitation

The EU’s budget deal sacrificed Horizon Europe – but now the fight can move to the parliament and the wider public

Newly appointed to its governing board, former MEP Paul Rübig says the European Institute of Innovation and Technology will play a key role in reviving innovation value chains - from shuttered universities, to cash strapped SMEs, to market

Viewpoint: ‘responsible research and innovation’ policies in Horizon 2020 don’t often translate into action, a new study shows. A broader, deeper effort is needed

COVID-19 has elevated, but also exposed scientists. Politicians want clarity, but it’s crucial to explain what is known, unknown and unknowable, says Rolf-Dieter Heuer, chair of the EU group of chief scientific advisers

The Labour Party’s Josianne Cutajar argues for broad investment in skills, and giving citizens more say in EU spending

Lega’s Paolo Borchia MEP argues that until there’s a recovery from COVID-19, big plans such as the Green Deal should be shelved

Two MEPs, from either end of the political spectrum, give their views on what the post-coronavirus budget should look like

Economic distancing will follow physical distancing as governments seek to increase resilience and strategic autonomy